217 related articles for article (PubMed ID: 27563802)
1. Rasburicase for Tumor Lysis Syndrome.
Vishwanathan S; Arumugarajah A; Ortega LM; Bousamra A
Am J Ther; 2019; 26(1):e118-e121. PubMed ID: 27563802
[No Abstract] [Full Text] [Related]
2. Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?
Canet E; Cheminant M; Zafrani L; Thieblemont C; Galicier L; Lengline E; Schnell D; Reuter D; Darmon M; Schlemmer B; Azoulay E
Leuk Lymphoma; 2014 Oct; 55(10):2362-7. PubMed ID: 24325633
[TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury associated with tumor lysis syndrome: a paradigm shift.
El-Husseini A; Sabucedo A; Lamarche J; Courville C; Peguero A
Am J Emerg Med; 2012 Feb; 30(2):390.e3-6. PubMed ID: 21296524
[No Abstract] [Full Text] [Related]
4. [Müllerian adenosarcoma of the uterus. A case report].
Irmscher S; Krüger G; Köppe I
Geburtshilfe Frauenheilkd; 1995 Feb; 55(2):115-7. PubMed ID: 7758893
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous Tumor Lysis Syndrome in Blastoid-Variant Mantle Cell Lymphoma: Considerations for the General Internist.
Patel V; Case R
J Investig Med High Impact Case Rep; 2020; 8():2324709620944709. PubMed ID: 32720820
[TBL] [Abstract][Full Text] [Related]
6. [Acute renal failure in patients with tumor lysis syndrome].
Nabeshima K; Saito S; Suzuki Y
Nihon Rinsho; 2004 May; 62 Suppl 5():486-90. PubMed ID: 15197969
[No Abstract] [Full Text] [Related]
7. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis.
Goldman SC; Holcenberg JS; Finklestein JZ; Hutchinson R; Kreissman S; Johnson FL; Tou C; Harvey E; Morris E; Cairo MS
Blood; 2001 May; 97(10):2998-3003. PubMed ID: 11342423
[TBL] [Abstract][Full Text] [Related]
8. Müllerian adenosarcoma of the uterus.
Ventura L; Leocata P; Santeusiano G; Coletti G; Partenzi A; Ventura T
J Exp Clin Cancer Res; 1997 Jun; 16(2):221-6. PubMed ID: 9261751
[TBL] [Abstract][Full Text] [Related]
9. Tumor lysis syndrome: new challenges and recent advances.
Wilson FP; Berns JS
Adv Chronic Kidney Dis; 2014 Jan; 21(1):18-26. PubMed ID: 24359983
[TBL] [Abstract][Full Text] [Related]
10. [Fast remission of acute kidney failure after rasburicase use in tumor lysis syndrome].
Viedma G; Borrego FJ; Pérez del Barrio P; de Santi C
Nefrologia; 2005; 25(5):572-3. PubMed ID: 16392310
[No Abstract] [Full Text] [Related]
11. [Rasburicase (Fasturtec)].
Vogt B; Gugger M; Frey FJ
Ther Umsch; 2004 Sep; 61(9):579-82. PubMed ID: 15493120
[TBL] [Abstract][Full Text] [Related]
12. [Acute renal failure in patients with tumour lysis sindrome].
Poskurica M; Petrović D; Poskurica M
Srp Arh Celok Lek; 2016; 144(3-4):232-9. PubMed ID: 27483573
[TBL] [Abstract][Full Text] [Related]
13. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
Cheuk DK; Chiang AK; Chan GC; Ha SY
Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
[TBL] [Abstract][Full Text] [Related]
14. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
Darmon M; Vincent F; Camous L; Canet E; Bonmati C; Braun T; Caillot D; Cornillon J; Dimicoli S; Etienne A; Galicier L; Garnier A; Girault S; Hunault-Berger M; Marolleau JP; Moreau P; Raffoux E; Recher C; Thiebaud A; Thieblemont C; Azoulay E;
Br J Haematol; 2013 Aug; 162(4):489-97. PubMed ID: 23772757
[TBL] [Abstract][Full Text] [Related]
15. [The pathophysiology, clinical signs and therapy of urate nephropathy].
Méhes L; Udvardy M; Szász R; Rejto L
Orv Hetil; 2007 Apr; 148(16):745-8. PubMed ID: 17437951
[TBL] [Abstract][Full Text] [Related]
16. Uterine pleomorphic rhabdomyosarcoma: a case report and review of literature.
Buresh RC; Laudenschlager MD; Bell MC; Koch MR
S D Med; 2011 Feb; 64(2):47-9. PubMed ID: 21476391
[TBL] [Abstract][Full Text] [Related]
17. Management of pediatric tumor lysis syndrome.
Tazi I; Nafl H; Elhoudzi J; Mahmal L; Harif M
Arab J Nephrol Transplant; 2011 Sep; 4(3):147-54. PubMed ID: 22026339
[TBL] [Abstract][Full Text] [Related]
18. Tumour lysis syndrome.
Calvo Villas JM
Med Clin (Barc); 2019 May; 152(10):397-404. PubMed ID: 30612747
[TBL] [Abstract][Full Text] [Related]
19. Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.
Vines AN; Shanholtz CB; Thompson JL
Ann Pharmacother; 2010 Oct; 44(10):1529-37. PubMed ID: 20841516
[TBL] [Abstract][Full Text] [Related]
20. Rational use of rasburicase for the treatment and management of tumor lysis syndrome.
Shaikh SA; Marini BL; Hough SM; Perissinotti AJ
J Oncol Pharm Pract; 2018 Apr; 24(3):176-184. PubMed ID: 28077046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
